Monday, November 10, 2008

3 Types of Natural Treatment For Nail Fungus

Nail fungal infection is a disorder that afflicts about 11 million Americans. It is prevalent especially in the older population because of their greater chance of exposure to fungus over the years and because of poor blood circulation. Doctors claim that the quickest and surefire way to treat nail fungus is from the inside through oral pharmaceutical drugs. While the chance for treating the disease is greater compared to other forms of remedy, these drugs have been proven dangerous to health especially when ingested for more than the prescribed dosage or for prolonged periods. They are also proven potentially fatal for patients with heart, liver or kidney disorders. For this reason, most patients prefer natural herbal treatments to nail fungus. Herbal treatments are regarded as safer compared to pharmaceutical drugs, not to mention more affordable. But the question of efficacy often clouds herbal treatments in general.

Circulating Tumor Cells Predict Survival Benefit From Treatment In Metastatic Castration-Resistant Prostate Cancer

UroToday.com - In the October 1, 2008 issue of Clinical Cancer Research, Dr. Johann de Bono and colleagues presented exciting data indicating that circulating tumor cells (CTC) predict overall survival (OS) in patients with castration-resistant prostate cancer (CRPC). CTC using the commercially available CellSearch is approved by the FDA as a prognostic indicator for patients with metastatic breast, prostate, and colorectal cancer. Read more ...

Radiological health expert Daniel Hayes, Ph.D., of the New York City Department of Health and Mental Hygiene suggests that a form of vitamin D could be one of our body's main protections against damage from low levels of radiation. Writing in the International Journal of Low Radiation, Hayes explains that calcitriol, the active form of vitamin D, may protect us from background radiation and could be used as a safe protective agent before or after a low-level nuclear incident. Read more ...

Over 520 guests reached into their pockets to the tune of over $1.15 million and cast their vote for increased funding for lymphoma-focused research at Vote For A Cure: the Lymphoma Research Foundation's (LRF) 2008 National Gala held on October 6 at the New York Marriot Marquis. Tom Brokaw, NBC News, shared emcee duties with Jeff Greenfield of CBS News for this very successful event. Read more ...

DxS, a personalised medicine company and market leaders in the provision of companion diagnostics are pleased to announce the addition of a PI3K Mutation Detection Kit to their portfolio of oncogene mutation products. PI3K is a biomarker assessed during the evaluation of the tyrosine kinase inhibitors targeting the EGFR pathway. The PI3K-AKT pathway is activated in a variety of tumour types resulting in cell growth and proliferation. Read more ...

Radical improvements in outcome for many cancer sufferers are in prospect following one of the most significant advances in radiotherapy since x-rays were first used to treat a tumour in 1904. The use of charged particles as an alternative to x-ray or gamma ray radiation can extend the scope of radiotherapy to tumours previously requiring invasive surgery, while speeding up diagnosis and reducing collateral damage to surrounding tissue. Read more ...

UroToday.com - Our single center study on robotic partial nephrectomy represents one of the largest series in the world. The study, which shows results comparable, if not better, than most laparoscopic series, is significant for the relatively short ischemic times and excellent pathological outcomes. Ultimately, the goal of robotic partial nephrectomy is similar to the open counterpart: to provide excellent cancer control with preservation of long term renal functional outcomes. Read more ...

DiaGenic ASA (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI) today announced the launch of BCtect(TM), a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature identified by DiaGenic using a custom TaqMan(R) Array manufactured for DiaGenic by Applied Biosystems. India was chosen as the first country for the introduction of BCtect(TM) after successful completion of a large study in the country. Read more ...

Dense networks of blood vessels thought to spur cancer's growth could actually hinder rather than promote tumor progression, according to a new study at the University of California, San Diego. The findings partly explain why drugs designed to treat cancer by strangling its blood supply have been disappointing when used alone and why those treatments are more effective when combined with traditional chemotherapy. Read more ...

Cardiovascular Disease Not Prevented By Supplementation With Vitamins E Or C

The risk of cardiovascular events is not reduced by vitamin E or vitamin C supplements, as determined in a large, long-term randomized study of male physicians, according to an article released on November 9, 2008 in JAMA to coincide with the scientific presentation of these findings at the current American Heart Association (AHA) meeting. More at...

Results from the latest clinical study evaluating the predictive value of VENDYS®, the new FDA-approved cardiovascular test, will be presented to cardiovascular opinion leaders and luminaries during the 2008 annual conference of the American Heart Association in New Orleans. The study shows that a simple, inexpensive test that measures temperature changes at the fingertips can help detect hidden coronary artery disease. More at...

Headphones for MP3 players placed within an inch of pacemakers and implantable cardioverter defibrillators (ICDs) may interfere with these devices, according to research presented at the American Heart Association's Scientific Sessions 2008. View the video news release here. More at...

An international trial found that the cholesterol busting drug rosuvastatin reduced heart attack and stroke in men and women with low cholesterol who had high levels of C-reactive protein but who were otherwise classed as healthy, and experts suggested this could be a class effect of all statins and not just rosuvastatin, which is marketed by AstraZeneca as Crestor. More at...

Hispanic patients were 57 percent less likely than Caucasian patients to undergo coronary artery bypass surgery (CABG) one year after successful angioplasty, a type of percutaneous coronary intervention (PCI) to open blockages in the coronary arteries. Hispanics also had a trend toward lower rates of overall repeat revascularization procedures including stenting and bypass surgery, according to a study presented at the American Heart Association's Scientific Sessions 2008. More at...

In examining health inequalities between the rich and the poor, the gap becomes narrower in areas with the greenest environments, according to an article released on November 7, 2008 in The Lancet. Previously, it has been shown that exposure to parks, forests, playing fields, and other "green space" has a beneficial effect on health and health-related behaviors that is independently significant. More at...